Related Experiment Videos
[Breastfeeding and drugs]
G Gremmo-Féger1, M Dobrzynski, M Collet
1Service de Gynécologie Obstétrique, CHU Brest. gisele.gremmo-feger@chu-brest.fr
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|September 18, 2003
Summary
Most drugs are safe during breastfeeding, with few posing significant risks to infants. Healthcare providers should carefully weigh the benefits of breastfeeding against potential drug risks for each mother-infant pair.
Area of Science:
- Pharmacology
- Pediatrics
- Public Health
Background:
- Breastfeeding provides numerous maternal and infant benefits.
- Drug use during breastfeeding presents a clinical dilemma, often leading to breastfeeding cessation.
- Few medications pose a clinically significant risk to breastfed infants.
Purpose of the Study:
- To review epidemiological data on infant adverse effects from maternal drug use during breastfeeding.
- To analyze pharmacokinetic data for managing drug exposure in breastfeeding.
- To provide data on specific drugs and information sources for healthcare providers.
Main Methods:
- Literature review of epidemiological and pharmacokinetic data.
- Analysis of drug transfer into breast milk.
- Evaluation of benefit/risk assessments for breastfeeding mothers taking medications.
Main Results:
- Most drugs have minimal or no adverse effects on breastfed infants.
- Individualized risk-benefit analysis is crucial when mothers require medication.
- Evidence-based information supports informed decision-making.
Conclusions:
- Breastfeeding can often be maintained even when mothers require medication.
- Careful evaluation of drug properties and infant exposure is essential.
- Healthcare providers should utilize evidence-based resources to guide decisions on breastfeeding and medication.